How do these specific nutrients relate to migraine?
The honest hierarchy: acute therapy (NSAIDs early, triptans, gepants) and indicated prevention (including the CGRP monoclonal antibodies that reset the field in 2018) are the medical spine, with exercise and regularity as the lifestyle spine. Behind them, three nutrients with three real mechanisms: magnesium (the threshold stabilizer — trials at 600 mg, guideline-listed), riboflavin (the mitochondrial energy cofactor — 400 mg trials, adult evidence), and CoQ10 (the electron-transport partner — one good small trial, honestly graded). All three share one instruction: they take months to judge — a migraine prevention trial is a season, not a week.
Guideline-directed care is two-sided. Acute: NSAIDs or acetaminophen at attack onset (before sensitization), triptans for moderate-severe attacks, gepants and antiemetics as alternatives — with the iron rule of ≤10 medication days/month. Prevention is indicated at 4+ headache days/month or with disabling attacks: beta-blockers, topiramate, amitriptyline-class, and the CGRP monoclonal antibodies — every preventive, drug or supplement, needs 6–8 weeks at full dose before judging. Nothing on this page replaces that ladder; everything on it can sit alongside it.
The strongest supplement evidence in migraine prevention: randomized trials at ~600 mg/day elemental reduced attack frequency, migraineurs as a group run lower magnesium status, and guidelines list it as a Level B preventive — the only supplement on this page with that standing. The honest cautions: the studied dose exceeds the 350 mg/day over-the-counter ceiling, and trials used oxide/citrate — the better-tolerated glycinate trades capsule math for comfort.
MECHANISM · Blocks NMDA-type glutamate receptors — the hyperexcitable cortex's main accelerator — and stabilizes the neuronal threshold against spreading excitation; also modulates CGRP release and vascular tone downstream.
⚠ Safety · 🚨 600 mg/day is a physician-conversation dose — above the unsupervised UL. Loose stools are the built-in ceiling and dose-limiting sign. Kidney disease makes supplementation clinical-only. IV magnesium has ER evidence for acute attacks — a hospital decision, not a home project.
The mitochondrial hypothesis's flagship: migraine brains may run marginal energy metabolism, and 400 mg daily riboflavin — ~250 times the dietary RDA — feeds the electron-transport chain's cofactor needs. The adult trial showed roughly half of patients improving over 3–4 months; a pediatric trial was negative, keeping the claim honestly adult-scoped. Guidelines mention it; the cost is pennies.
MECHANISM · Flavin cofactors (FAD/FMN) are required for mitochondrial electron transport and energy (ATP) production — the theorized weak link in the hyperexcitable migraine cortex's energy budget.
⚠ Safety · Among the safest high-dose vitamins known — water-soluble, no established toxicity at this dose. Bright yellow urine is expected and harmless. The commitment is the barrier: no judgment before 3 months.
The same mitochondrial story's third leg: CoQ10 shuttles electrons down the transport chain riboflavin's cofactors power. One randomized trial (100 mg three times daily, 42 patients) improved responder rates substantially — promising, single, small. Listed here for mechanism coherence and honest grading, ranked third accordingly. Takes the same months-to-judge patience as the rest.
MECHANISM · Electron transport between mitochondrial complexes I/II and III — the bottleneck cofactor for ATP production. CoQ10 also carries independent cardiovascular trial evidence (see our hypertension page) — a supplement with two honest homes.
⚠ Safety · Generally well tolerated; fat-soluble, take with a fat-containing meal. 🚨 Case reports of reduced warfarin effect — physician involvement if anticoagulated (the same flag our hypertension page carries).
We categorize nutritional research based on the strength of available clinical data:
Ingrid, 33, had tracked her attacks for a decade: six to eight a month, clustered around her cycle, worse after project deadlines. Her diary's medication column showed the danger — 11 triptan days in her worst month. Her neurologist's plan had four parts: a CGRP monoclonal antibody, the let-down wind-down ritual, fixed wake times, and magnesium plus riboflavin alongside.
Judged honestly at month four (the season the supplements require): attack frequency down to two to three per month, triptan days under five, and the weekend attack — her most reliable one — simply gone once the wake time held steady.